Bixiye
QP81-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Risdiplam PA with QL
Taariikhda barnaamijka Dhaqangalayso Agosto 26, 2020
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2331 - 2340 ee natiijooyinka 3167
Bixiye
QP79-20 Introducing the Blue Cross Blue Shield System’s New National High-Performance Network
Taariikhda barnaamijka Dhaqangalayso Agosto 26, 2020
Bixiye
2020 September Provider Press
Taariikhda barnaamijka Dhaqangalayso Agosto 19, 2020
Bixiye
QP73-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Bempedoic Acid PA with QL
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
QP72-20 MHCP Pharmacy Benefit Update – Pharmacy Benefit Exclusion for Anjeso™, Fetroja®, Herzuma®, Ontruzant®, Potassium Phosphates, Scenesse® and Trazimera™
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
QP71-20 MHCP Pharmacy Benefit Update: Pharmacy Benefit Exclusion for Phesgo™, Uplizna™, and Zepzelca™
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
QP75-20 Commercial Pharmacy Benefit Exclusion for Aralast®NP, Eylea®, Glassia®, Lucentis®, Prolastin®-C, and UpliznaTM
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
QP70-20 In-Home Test Kits 2020 Program Details for Medicare Advantage and SecureBlue Members
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
QP76-20 Outlier Outpatient Therapy Management Program
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
QP74-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Isturisa PA with QL
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020